Interviews

Lourdes Weltzien, PhD

Meridian Bioscience is a life sciences and diagnostics company specializing in developing innovative diagnostic solutions, reagents, and raw materials for infectious disease testing, oncology screening, and life science research.

Sean A. MacDonald

Domain Therapeutics is a biotech company specializing in drug discovery and development targeting G-protein-coupled receptors (GPCRs) for immuno-oncology and inflammatory diseases.

Roland Rott

GE HealthCare is a global leader in medical technology, diagnostics, and digital solutions, focused on improving patient outcomes and advancing precision healthcare.

Thomas Van Valkenburgh

Lars Petersen

FUJIFILM Diosynth Biotechnologies is a global contract development and manufacturing organization (CDMO), with a focus on trust-based partnerships and large-scale commercial production.

Michael Morrissey, Ph.D.

Exelixis is a biopharmaceutical company headquartered in Alameda, California, that specializes in oncology. Working with both small molecules and biotherapeutics, it discovers, develops and commercializes treatments for difficult-to-treat cancers.

Rami Elghandour

Arcellx is a biotechnology company focused on developing innovative cell therapies, particularly CAR-T treatments, to address unmet needs in cancer and other serious diseases.

Jacob Thaysen

Illumina is a leading biotechnology company specializing in next-generation sequencing (NGS) and genomic analysis, enabling advancements in precision medicine, diagnostics, and life sciences research.

Dawn Sherman

ProPharma Group is a global provider of comprehensive pharma services solutions, supporting clients across the entire lifecycle of drug development, from preclinical stages to commercialization.

Andreas Pahl

Heidelberg Pharma develops innovative cancer treatments using proprietary Antibody-Drug Conjugate (ADC) technologies, including an unique platform using the Amanitin toxin from green death cap mushrooms. Its lead product candidate HDP-101 targets multiple myeloma.